Insider Trading & Ownership - Schorno Dean L

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Schorno Dean L
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-02
Sale
2024-02-06
8:18 pm
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
12,628$1.1354$14,338402,891
(Direct)
View
2023-02-02
Sale
2023-02-06
5:40 pm
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
5,389$1.6601$8,946196,519
(Direct)
View
2019-05-22
Purchase
2019-05-23
8:21 pm
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP &Chief Financial Officer
50,000$2.1309$106,54450,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-28
Option Award
2024-03-01
7:16 pm
N/A
2033-01-26
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
141,000$0141,000
(Direct)
View
2024-01-23
Option Award
2024-01-25
9:16 pm
N/A
2034-01-23
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
366,000$0572,519
(Direct)
View
2023-01-26
Option Award
2023-01-30
9:45 pm
N/A
2032-01-24
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
238,000$0426,908
(Direct)
View
2022-12-28
Option Award
2022-12-30
4:30 pm
N/A
2032-01-24
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
50,000$050,000
(Direct)
View
2022-09-14
Option Award
2022-09-16
4:15 pm
N/A
2029-01-23
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
81,250$081,250
(Direct)
View
2022-01-24
Option Award
2022-01-26
8:47 pm
N/A
2032-01-24
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP &Chief Financial Officer
150,000$0228,908
(Direct)
View
2021-11-04
Option Award
2021-11-05
7:06 pm
N/A
2029-01-23
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP & Chief Financial Officer
81,250$081,250
(Direct)
View
2021-04-01
Option Award
2021-04-02
6:23 pm
N/A
2030-02-06
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP &Chief Financial Officer
50,000$050,000
(Direct)
View
2021-01-27
Option Award
2021-01-29
6:55 pm
N/A
2031-01-27
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP &Chief Financial Officer
112,500$0112,500
(Direct)
View
2020-02-06
Option Award
2020-02-07
6:16 pm
N/A
2030-02-06
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP &Chief Financial Officer
200,000$0200,000
(Direct)
View
2019-11-18
Option Award
2019-11-20
8:23 pm
N/A
2028-06-04
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP &Chief Financial Officer
83,750$083,750
(Direct)
View
2019-03-20
Option Award
2019-03-22
7:28 pm
N/A
2028-06-04
RIGEL PHARMACEUTICALS INCRIGLSchorno Dean L
EVP &Chief Financial Officer
83,750$083,750
(Direct)
View